Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis Having Coronary Cusp Fusion versus Mixed Cusp Fusion Nonraphe Bicuspid Aortic Valve
Table 1
Baseline characteristics.
Characteristic
Total (N = 71)
Mixed fusion (N = 44)
Coronary fusion (N = 27)
value
Age (years)
71.9 ± 5.8
71.5 ± 6.1
72.6 ± 5.4
0.44
Male sex
32 (45.1%)
20 (45.5%)
12 (44.4%)
1.0
Body mass index (kg/m2)
22.3 ± 3.4
22.2 ± 3.5
22.5 ± 3.2
0.80
Body surface area (m2)
1.65 ± 0.13
1.65 ± 0.14
1.64 ± 0.12
0.84
STS score (%)
7.0 ± 3.6
6.9 ± 4.0
7.2 ± 3.0
0.76
NYHA class III/IV
63 (88.7%)
39 (88.6%)
24 (88.9%)
1.0
Creatinine (mg/dL)
0.9 (0.8–1.1)
0.9 (0.7–1.1)
0.93 (0.86–1.1)
0.13
Hypertension
32 (45.1%)
18 (40.9%)
14 (51.9%)
0.46
Diabetes
14 (19.7%)
8 (18.2%)
6 (22.2%)
0.76
Chronic lung disease
37 (52.1%)
22 (50%)
15 (55.6%)
0.81
Coronary artery disease
25 (35.2%)
15 (34.1%)
10 (37.0%)
1.0
Peripheral vascular disease
36 (50.7%)
23 (52.3%)
13 (48.1%)
0.81
Cerebral vascular disease
16 (22.5%)
11 (25%)
5 (18.5%)
0.57
Chronic kidney disease
6 (8.5%)
3 (6.8%)
3 (11.1%)
0.67
Previous myocardial infarction
2 (2.8%)
1 (2.3%)
1 (3.7%)
1.0
History of permanent pacemaker
3 (4.2%)
2 (4.5%)
1 (3.7%)
1.0
Cancer
3 (4.2%)
3 (6.8%)
0
0.28
The patients were stratified according to the type of cusp fusion. Data are shown as mean ± standard deviation, frequency (percentage), or median (range). NYHA, New York Heart Association; STS, Society of Thoracic Surgeons.
